AtriCure - 14 Year Stock Price History | ATRC

Historical daily share price chart and data for AtriCure since 2005 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for AtriCure as of February 15, 2019 is 33.19.
AtriCure Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 30.9209 30.2500 33.3400 29.2000 33.1900 8.46%
2018 26.1470 18.4700 35.5800 15.0500 30.6000 67.76%
2017 20.3076 19.2000 24.8800 14.9400 18.2400 -6.80%
2016 16.5649 21.1600 21.4700 13.5400 19.5700 -12.79%
2015 21.8535 19.7800 27.9300 17.4000 22.4400 12.42%
2014 17.5247 18.0300 22.1800 13.6400 19.9600 6.85%
2013 10.3316 7.1400 18.9300 7.1400 18.6800 170.72%
2012 8.5684 11.7400 11.9600 5.9100 6.9000 -37.84%
2011 11.4511 10.2500 14.5000 8.5400 11.1000 8.08%
2010 6.7755 5.6500 10.2700 4.5600 10.2700 70.03%
2009 3.2447 2.2000 6.0500 1.0700 6.0400 172.07%
2008 9.7793 13.2400 14.0500 2.0000 2.2200 -83.07%
2007 10.6159 9.1500 13.5900 8.4400 13.1100 46.64%
2006 8.1361 10.7900 11.8000 5.4400 8.9400 -16.06%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.269B $0.175B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.916B 25.68
Medtronic (MDT) Ireland $122.526B 18.32
Stryker (SYK) United States $69.144B 25.38
Boston Scientific (BSX) United States $55.241B 26.97
Baxter (BAX) United States $38.548B 23.75
Zimmer Biomet Holdings (ZBH) United States $24.985B 16.03
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
ResMed (RMD) United States $14.250B 27.02
Canopy Growth (CGC) Canada $10.707B 0.00
Bio-Rad Laboratories (BIO) United States $7.832B 50.08
Aurora Cannabis (ACB) Canada $7.090B 50.71
Hill-Rom Holdings (HRC) United States $6.904B 21.35
Perrigo (PRGO) Ireland $6.603B 10.02
ICU Medical (ICUI) United States $5.119B 28.52
Insulet (PODD) United States $5.012B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.563B 0.00
Haemonetics (HAE) United States $4.395B 38.99
Agios Pharmaceuticals (AGIO) United States $3.341B 0.00
Hutchison China MediTech (HCM) China $3.330B 0.00
Neogen (NEOG) United States $3.259B 50.06
NuVasive (NUVA) United States $3.008B 27.99
National Vision Holdings (EYE) United States $2.570B 49.72
Quidel (QDEL) United States $2.529B 22.88
Aphria (APHA) $2.274B 101.00
NxStage Medical (NXTM) United States $1.945B 0.00
VAREX IMAGING (VREX) United States $1.196B 23.42
Phibro Animal Health (PAHC) United States $1.192B 17.13
Cardiovascular Systems (CSII) United States $1.151B 826.00
HEXO (HEXO) $1.127B 0.00
MacroGenics (MGNX) United States $0.893B 0.00
Cerus (CERS) United States $0.848B 0.00
PetIQ (PETQ) United States $0.821B 21.28
Evolus (EOLS) United States $0.744B 0.00
Surmodics (SRDX) United States $0.724B 105.35
NanoString Technologies (NSTG) United States $0.721B 0.00
Lantheus Holdings (LNTH) United States $0.711B 22.00
OraSure Technologies (OSUR) United States $0.707B 31.19
Omeros (OMER) United States $0.703B 0.00
Meridian Bioscience (VIVO) United States $0.698B 20.80
Eagle Pharmaceuticals (EGRX) United States $0.604B 19.39
Quanterix (QTRX) United States $0.491B 0.00
LeMaitre Vascular (LMAT) United States $0.486B 23.89
Owens & Minor (OMI) United States $0.470B 5.32
TG Therapeutics (TGTX) United States $0.390B 0.00
Insys Therapeutics (INSY) United States $0.355B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.98
BioLife Solutions (BLFS) United States $0.285B 385.00
Bovie Medical (APYX) United States $0.283B 0.00
Vapotherm (VAPO) United States $0.279B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.272B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.228B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.152B 0.00
Fonar (FONR) United States $0.147B 7.87
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.11
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.079B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.53
Conatus Pharmaceuticals (CNAT) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Neurotrope (NTRP) United States $0.033B 0.00
Senestech (SNES) United States $0.020B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14